BROOKE ASHLEY: Open Payments
NPI 1750831731 · HARRISONBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,249 in 117 payments from 17 companies in 2025. Trend: 2023 $17 · 2024 $1,063 · 2025 $2,249
Food & beverage: $2,249
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $644 |
| Novo Nordisk Inc | 20 | $450 |
| PFIZER INC. | 22 | $309 |
| Axsome Therapeutics, Inc. | 10 | $209 |
| Lilly USA, LLC | 5 | $103 |
| AstraZeneca Pharmaceuticals LP | 5 | $99 |
| Astellas Pharma US Inc | 4 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
| Phathom Pharmaceuticals, Inc. | 2 | $53 |
| Abbott Laboratories | 2 | $42 |
Products named: NURTEC ODT, UBRELVY, VRAYLAR, Auvelity, Ozempic, QULIPTA, Wegovy, Veozah.
Industry payments across VA — which companies pay providers there.
